Article

Colon Cancer and Lynch Syndrome: Know Your Risks

Author(s):

As Colon Cancer Awareness Month approaches, know your risks for both cancer and Lynch Syndrome, a genetic syndrome that could make you more susceptible to a number of different cancers.

March is Colon Cancer Awareness Month and the American Cancer Society predicts that this year alone, more than 95,000 people will be diagnosed and nearly 50,000 people will die from the disease.

About three percent of all people who have colorectal cancer have Lynch Syndrome, an inherited cancer susceptibility syndrome caused by mutations in one of five DNA mismatch repair (MMR) genes.

Lynch Syndrome is passed down in families in a pattern called autosomal dominant, meaning that each child has a 50% chance to inherit the mutation. These carriers have a substantially increased risk of cancers of the colon, rectum, and endometrium, and they typically get it at younger agest than the rest of the population.

Since colorectal cancer can be life-threatening, it is highly advised for everyone to start being tested at the age of 50. But since those with Lynch syndrome are at a high risk of developing cancer before that, they should be screened earlier and with greater frequency. A simple colonoscopy can be life saving by simply removing the polyps before they have the potential to become cancerous.

If your family medical history includes: three or more relatives with cancer (especially colorectal cancer, or cancer of the endometrium, small intestine, ureter or renal pelvis), two or more successive generations that have been affected by cancer, or one or more relatives diagnosed before the 50 years old, then talk to you doctor and ask for a referral to a genetic counselor to access your risk. Or, go to: The National Society of Genetic Counselors to find a certified genetic counselor near you.

For more information, please go to:

www.ihavelynchsyndrome.com

In honor of Colon Cancer Awareness Month and Lynch Syndrome Awareness Day on March 22nd, #Hcchat on Twitter will be discussing What you need to know about immunotherapy and Lynch Syndrome-related cancers this week. Please join us; if you are unable to participate, you can always read the transcript on Twitter.

HC Chat

HC Chat

Yours,Georgia M. Hurst, MAFounder and Director of ihavelynchsyndrome.com (501c3)

Newsletter

Stay up to date on cancer updates, research and education

Related Videos
Waldenstrom macroglobulinemia is often slow growing, with high survival but lower quality of life over time, explained researcher Alisha Kimble.
Image of woman.
Image of two doctors and text.
Combining JNJ-1900 with Keytruda may improve distant control of lung cancer, explained by Dr. Jared Weiss.
image of serzan.
Dr. Breelyn Wilky explains that personalized treatments are helping improve outcomes for patients with gastrointestinal stromal tumors.
Image of two doctors with text.
Image of doctors with text.
Imiage of two doctors with text.
Treatment with zanzalintinib plus Opdivo and Opdualag is an option worth exploring in patients with previously untreated clear cell renal cell carcinoma
Related Content